JPRN-UMIN000008429招募中2 期
Phase II study of XELOX as adjuvant chemotherapy for locally advanced rectal cancer - CORONAII
Chubu Clinical Oncology Group(CCOG)0 个研究点目标入组 40 人开始时间: 2012年7月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Multiple malignacies to be treated (2)Uncontrollable peptic ulcer disease (3)Serious complications (4)Previous history of severe drug-induced allergy (5)Severe neuropathy (6)With interstitial lung disease or pulmonary fibrosis (7)Pregnant (8)Prior chemotherapy with oxaliplatin or capecitabin (9)Disqualified by attending doctor
研究者
相似试验
已完成
不适用
Pilot study of preoperative chemotherapy of XELOX+ Bevacizumab in patients with locally-advanced lower rectal cancerRectal cancerJPRN-UMIN000003219Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group20
Unknown
3 期
Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver MetastasisResectable Liver MetastasisColorectal CancerNCT00630045Peking University People's Hospital392
招募中
2 期
Phase II study of XELOX as perioperative chemotherapy for locally advanced rectal cancerocally advanced rectal cancerJPRN-UMIN000008316agoya Surgical Oncology Group60
招募中
2 期
Phase2 trial of Preoperative chemotherapy with XELOX prus Bv for resectable liver metastases from colorectal cancercolon cancerJPRN-UMIN000007931Sano HospitalGastrointestinal Center30
已完成
2 期
Phase II trial of neoadjuvant chemotherapy with XELOX plus Bevacizumab for locally advanced rectal cancerocally advanced rectal cancerJPRN-UMIN000003507agoya Surgical Oncology Group30